-
Symbol
-
GLMD on Nasdaq
-
Investment type
-
Equity / Ordinary Shares, NIS 1.80 par value per share
-
Latest Disclosed Shares Owned
-
44,128 shares
-
Security Ownership %
-
2.6%
Allen Baharaff ownership in Galmed Pharmaceuticals Ltd. Ordinary Shares, NIS 1.80 par value per share (GLMD)
18 Feb 2025 - Allen Baharaff has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 44,128 shares of Galmed Pharmaceuticals Ltd. Ordinary Shares, NIS 1.80 par value per share (GLMD).
This represents 2.6% ownership of the company.
This is the first filing by Allen Baharaff disclosing ownership of Galmed Pharmaceuticals Ltd. Ordinary Shares, NIS 1.80 par value per share (GLMD).